ArticleAdvances in therapy2020

Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis.

Cedric Hermans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.